Artificial Intelligence May Discover the Next Blockbuster Drug - MIT Technology Review

Artificial Intelligence May Discover the Next Blockbuster Drug
MIT Technology Review
Ken Mulvaney, CEO of Benevolent AI, discusses the opportunities and challenges that come with applying machine learning to drug development. by Will Knight; June 12, 2017. AI is revolutionizing countless industries, but its biggest impact may be felt ...